National Cancer Institute, Department of Tumors of Abdominal Cavity and Retroperitoneum

Kiev 03022

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Pancreatic Adenocarcinoma

Studies at this site

• A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP) — Completed